Journal of Drug Resistant Pathogen Research

Journal of Drug Resistant Pathogen Research

Journal of Drug Resistant Pathogen Research – Call For Papers

Open Access & Peer-Reviewed

Submit Manuscript
40%Max Discount
3Free Papers
48hFast Review
60+Countries

Call for Papers: Drug Resistant Pathogen Research

We invite original research, reviews, and methodological advances focused on antimicrobial resistance, drug-resistant pathogens, and innovative interventions that protect public health worldwide.

Scope of the Journal

The Journal of Drug Resistant Pathogen Research publishes high-impact work on resistance mechanisms, pathogen evolution, novel therapeutics, diagnostics, surveillance, and stewardship. We welcome studies from clinical microbiology, infectious disease medicine, pharmacology, molecular biology, epidemiology, veterinary science, and public health.

Submissions should demonstrate rigorous methodology and clear relevance to the prevention, detection, or treatment of drug-resistant infections. Interdisciplinary studies that connect basic science to clinical application are strongly encouraged.

Priority Research Themes

We are particularly interested in manuscripts that address urgent AMR challenges and translate into actionable insights for clinical care and policy.

Resistance Mechanisms

Genetic and phenotypic pathways driving resistance, including horizontal gene transfer, efflux systems, and biofilm persistence.

Novel Therapeutics

New antibiotics, adjuvants, phage therapies, antimicrobial peptides, and combination strategies that address MDR and XDR pathogens.

Rapid Diagnostics

Innovations in rapid pathogen detection, susceptibility testing, and genomic surveillance for clinical and public health use.

Stewardship and Policy

Programs, interventions, and outcomes that reduce resistance and improve antimicrobial use.

Why Publish with JDRPR

Our editorial board includes leading experts in AMR, infectious diseases, and clinical microbiology. We provide fair peer review, clear communication, and open access distribution to ensure your findings reach researchers, clinicians, and decision-makers quickly.

Rigorous Review

Expertise

Specialist reviewers evaluate methodology and clinical relevance

  • Scope and ethics screening
  • Subject-matter peer review
  • Integrity and data checks
  • Clear decision rationale

Author Support

Guidance

Editorial coordination to keep projects on track

  • Pre-submission guidance
  • Revision support
  • Transparent timelines
  • Professional production

Article Types

We publish original research, systematic reviews, short communications, methods papers, surveillance reports, and perspectives that advance understanding of drug-resistant pathogens.

Transparency

Include data availability statements and disclose any conflicts of interest.

Reproducibility

Provide detailed methods and validated diagnostics or assays.

Clinical Impact

Explain how findings affect treatment, stewardship, or surveillance.

Peer Review Timeline

We aim for rapid initial assessment and timely decisions while maintaining rigorous standards. Reviewers are selected based on domain expertise to ensure technically accurate and clinically relevant feedback.

1

Initial Check

Scope, ethics, and completeness review

2

Expert Review

Two or more specialist reviewers evaluate the manuscript

3

Decision

Clear editorial feedback and guidance for revisions

4

Publication

Accepted articles released open access with full metadata

Two Submission Methods

We offer two convenient submission routes to match your workflow preferences.

ManuscriptZone

Full-featured submission and tracking with reviewer communication tools.

Submit via ManuscriptZone

Simple Submission Form

Fast manuscript upload without a full portal login.

Submit via Form

What Makes a Strong Submission

Strong manuscripts present clear novelty, validated methods, and evidence that supports clinical or public health relevance. For resistance studies, describe the diagnostic approach, resistance criteria, and the clinical or epidemiological implications of the findings.

For therapeutic or diagnostic innovations, include validation against current standards of care and describe limitations transparently. Submissions with clear data availability statements and well documented methods are prioritized for efficient review.

Ethics and Transparency

All submissions must disclose funding sources, conflicts of interest, and ethical approvals where applicable. Clinical studies should describe consent procedures, cohort selection, and data privacy safeguards. Transparent reporting builds trust and improves review quality.

Submission Readiness Checklist

Before submitting, ensure your manuscript meets these essentials: a focused abstract, complete methods, labeled figures and tables, data availability statement, and references with DOIs when available. A concise cover letter that explains novelty and scope alignment helps editors select appropriate reviewers quickly.

Emerging Topics We Encourage

We welcome research on AMR in resource-limited settings, novel surveillance models, pathogen-host interactions that influence resistance, and implementation science that improves stewardship at scale. Studies that integrate genomics with clinical outcomes or link laboratory evidence to policy impact are especially valuable.

Submission Timing and Support

Submitting early allows more time for peer review and revisions, improving the likelihood of publication within planned issue windows. If you have questions about fit, send a brief abstract to the editorial office for guidance.

Interdisciplinary and Translational Work

We encourage submissions that connect laboratory discoveries with clinical implementation, such as studies linking resistance mechanisms to patient outcomes, diagnostics to stewardship impact, or surveillance data to policy change. Translational and implementation science that improves treatment decisions and infection control is especially valuable.

Rapid Communication Opportunities

Short communications that report time-sensitive findings, outbreak data, or early diagnostic results are welcome when supported by robust evidence. Clearly state the urgency and public health relevance in the abstract to help editors prioritize review.

Formatting Expectations

Ensure methods are detailed, figures are labeled, and data availability statements are included. Clear formatting speeds review and improves the chance of timely publication.

Regional and Global Relevance

We value studies that connect local resistance trends with global implications. Manuscripts that compare settings, describe surveillance networks, or propose scalable interventions help readers translate findings into action.

Share Your AMR Breakthroughs

Help shape the global response to drug-resistant infections with high-impact, open access publishing.